Drug intelligence / Profile preview

hydrocortisone acetate + bacitracin zinc + neomycin sulfate + polymyxin b

Development stage
Approved
Lead developer
Bausch + Lomb
Modality
Small Molecules
Administration
Ophthalmic, Topical
01

Overview

Hydrocortisone acetate + bacitracin zinc + neomycin sulfate + polymyxin b is a topical ophthalmic combination drug formulated as a sterile ointment for steroid-responsive inflammatory ocular conditions in which bacterial infection is present or there is a risk of bacterial infection. The product combines three antibacterial small molecules with a corticosteroid: bacitracin inhibits bacterial cell wall synthesis, polymyxin b disrupts bacterial cell membrane permeability, neomycin inhibits bacterial protein synthesis by binding the bacterial 30S ribosomal subunit, and hydrocortisone acetate activates the glucocorticoid receptor to suppress ocular inflammation. It is used for inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, including chronic anterior uveitis, conjunctivitis, and corneal injury from chemical, thermal, or radiation burns or foreign body penetration. It is marketed in the United States as Neo-Polycin HC and is also available as a generic ophthalmic ointment from multiple manufacturers.

Brand names
Neo-Polycin HC
Other names
neomycin sulfate + polymyxin b sulfate + bacitracin zinc + hydrocortisone acetate ophthalmic ointmenthydrocortisone acetate + bacitracin zinc + neomycin sulfate + polymyxin b ophthalmic ointment
02

Targets

GR (Glucocorticoid receptor)Undecaprenyl phosphate lipid carrier cycleBacterial Ribosome

Beyond the preview

Go deeper on hydrocortisone acetate + bacitracin zinc + neomycin sulfate + polymyxin b.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone acetate + bacitracin zinc + neomycin sulfate + polymyxin b.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call